Cardiac MOA Flashcards
Thiazides
Reduce peripheral resistance; reduced sodium and water retention–> decreased cardiac output
Loops
Block Na+ and Cl- reabsorption in kidney (can be used in poor renal function); Cause decreased renal vascular resistance and increased renal blood flow
K+ Sparing Diuretic
Inhibit Sodium transport at late distal and collecting ducts (fluid stays in urine)
Aldosterone Antagonist
Aldosterone receptor antagonists; diminish cardiac remodeling in HF
Nonselective BB
Block Beta 1 and 2 Receptors (decrease CO, decreases sympathetic outflow, inhibit release of renin)
Cardioselective BB
Block Beta 1 Receptors
Mixed Selective BB
Block alpha 1, Beta 1 and 2 - causes vasodilation
Dihydropyridines
Peripheral dilation of arterioles via 1)blocking the movement of calciuminto smooth muscle cells to prevent contraction 2)Does not dilate veins
Nondihydropyridines
Heart and peripheral dilation of arterioles via 1)blocking the movement of calciuminto smooth muscle cells to prevent contraction 2)Does not dilate veins3)Decreases cardiac output
ACE Inhibitors
Inhibit conversion of angiotensin l to angiotensin ll to reduce BP
ARBs
Block angiotensin l from binding to angiotensin ll receptor to reduce BP
Direct Renin Inhibitors
Directly inhibits renin
Alpha-1 Antagonists
Block alpha 1 receptors (causes vasodilation, decrease peripheral resistance, decrease BP)
Alpha-2 Agonist
Centrally mediated-Reduce sympathetic outflow; enhance parasympathetic activity; reduceing HR, CO, total PR
Peripheral Sympathetic Inhibitors
Reduces sympathetic tone and PR; depletes NE from sympathetic nerve endings
Direct Vasodilators
Relax smooth muscles in arterioles; activates baroreceptors
IV Vasodilators
Acts as source of NO-smooth muscle relaxation in arteries and veins; decreases preload
Positive Inotropes
Causes vasodilation
Statins
HMG-CoA Reductase Inhibitors; reduce lipoprotein oxidation; enhance endothelium synthesis of nitric oxide and inhibit thrombus
Cholesterol Absorption Inhibitors
Inhibits cholesterol absorption in the small intestine, preventing delivery to liver–>increase in clearance of cholesterol from blood (cholesterol ends up getting pulled from other parts of the body)
PCSK9 Inhibitors
Inhibits binding of PCSK9 to LDL receptors on hepatocytes-more receptors to clear LDL from circulation
Bile Acid Sequestrants
Bind to bile acids in the gut, which are then excreted (taken out of circulation to fulfil bodies need)
Nicotinic Acid
Inhibits fatty acid release from adipose tissue and inhibits fatty acid and triglyceride production in liver cells
Fibric Acid Derivatives
Activates PPAR-alpha, leading to the destruction and removal of triglycerides; increases HDL